This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement…
- Investigator
- Dennie Jones
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All